Individuals on a GLP-1 receptor drug reported the following: 65% reported nausea, compared to 16% of placebo 37% reported abdominal pain, compared to 6% of placebo
Overall, whilst these findings imply that increased production of ROS is associated with C9orf72-ALS, it is unclear whether loss of C9orf72 or expression of hexanucleotide repeat expansions disturbs redox homeostasis
Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress
Premium Essential Skin Conditioner Silk Mask Set What is it
Malerba M, Clini E, Cremona G, et al
PMOS is an endocrine disorder with broader metabolic manifestations, which can include obesity, insulin resistance, acne, hirsutism, and elevated long-term risk of diabetes and cardiovascular disease